$500,000,000 aggregate principal amount of their registered 6.100% First Lien Notes due 2027 (the “2027 Exchange Notes”) for a like amount of the Issuers’ outstanding unregistered 6.100% First Lien Notes due 2027 that were issued on April 9, 2020 (the “2027 Outstanding Notes”), which were offered and sold in reliance upon Rule 144A and Regulation S under the Securities Act, (vii) $1,750,000,000 aggregate principal amount of their registered 5.300% First Lien Notes due 2029 (the “2029 Exchange Notes”) for a like amount of the Issuers’ outstanding unregistered 5.300% First Lien Notes due 2029 that were issued on March 20, 2019 (the “2029 Outstanding Notes”), which were offered and sold in reliance upon Rule 144A and Regulation S under the Securities Act, (viii) $750,000,000 aggregate principal amount of their registered 6.200% First Lien Notes due 2030 (the “2030 Exchange Notes”) for a like amount of the Issuers’ outstanding unregistered First Lien Notes due 2030 that were issued on April 9, 2020 (the “2030 Outstanding Notes”), which were offered and sold in reliance upon Rule 144A and Regulation S under the Securities Act, (ix) $1,500,000,000 aggregate principal amount of their registered 8.100% First Lien Notes due 2036 (the “2036 Exchange Notes”) for a like amount of the Issuers’ outstanding unregistered 8.100% First Lien Notes due 2036 that were issued on June 1, 2016 (the “2036 Outstanding Notes”), which were offered and sold in reliance upon Rule 144A and Regulation S under the Securities Act, and (x) $2,000,000,000 aggregate principal amount of their registered 8.350% First Lien Notes due 2046 (the “2046 Exchange Notes” and, together with the 2023 Exchange Notes, the 2024 Exchange Notes, the 2025 Exchange Notes, the June 2026 Exchange Notes, the October 2026 Exchange Notes, the 2027 Exchange Notes, the 2029 Exchange Notes, the 2030 Exchange Notes and the 2036 Exchange Notes, the “Exchange Notes”) for a like amount of the Issuers’ outstanding unregistered 8.350% First Lien Notes due 2046 that were issued on June 1, 2016 (the “2046 Outstanding Notes” and, together with the 2023 Outstanding Notes, the 2024 Outstanding Notes, the 2025 Outstanding Notes, the June 2026 Outstanding Notes, the October 2026 Outstanding Notes, the 2027 Outstanding Notes, the 2029 Outstanding Notes, the 2030 Outstanding Notes and the 2036 Outstanding Notes, the “Outstanding Notes”), which were offered and sold in reliance upon Rule 144A and Regulation S under the Securities Act. The Outstanding Notes are, and the Exchange Notes will be, fully and unconditionally guaranteed by the Guarantors, who are also Registrants under the S-4 Registration Statement.
The Registrants are registering the exchange offer on the S-4 Registration Statement in reliance on the position of the Securities and Exchange Commission (the “Commission”) enunciated in Exxon Capital Holdings Corp., available May 13, 1988 (“Exxon Capital”), Morgan Stanley & Co., Inc., available June 5, 1991 (regarding resales) and Shearman & Sterling, available July 2, 1993 (with respect to the participation of broker-dealers.) In connection with the S-4 Registration Statement, the Registrants hereby confirm and represent as follows:
1. The Registrants have not entered into any arrangement or understanding with any person to distribute the Exchange Notes and, to the best of each of the Registrants’ information and belief without independent investigation, each person participating in the exchange offer is acquiring the Exchange Notes in its ordinary course of business and is not engaged in, does not intend to engage in, and has no arrangement or understanding with any person to participate in, the distribution of the Exchange Notes. In this regard, the Registrants will disclose to each person participating in the exchange offer that if such person is participating in the exchange offer for the purpose of distributing the Exchange
-2-